Terumo (Terumo) Total Equity : $8,446 Mil (As of Dec. 2023)

View and export this data going back to 2008. Start your Free Trial

What is Terumo Total Equity?

Terumo's total equity for the quarter that ended in Dec. 2023 was $8,446 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Terumo Total Equity Historical Data

The historical data trend for Terumo's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Terumo Total Equity Chart

Terumo Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Total Equity

Get a 7-Day Free Trial

6,281.13

7,011.25

7,881.04

8,537.15

8,312.34

Terumo Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Equity	Get a 7-Day Free Trial															7,958.44	8,312.34	8,507.90	8,529.18	8,445.61

Terumo Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Terumo's Total Equity for the fiscal year that ended in Mar. 2023 is calculated as

Total Equity	=	Total Assets(Q: Mar. 2023 )	-	Total Liabilities(Q: Mar. 2023 )
	=	11986.933	-	3674.594
	=	8,312

Terumo's Total Equity for the quarter that ended in Dec. 2023 is calculated as

Total Equity	=	Total Assets(Q: Dec. 2023 )	-	Total Liabilities(Q: Dec. 2023 )
	=	11749.197	-	3303.591
	=	8,446

Terumo Total Equity Related Terms

Thank you for viewing the detailed overview of Terumo's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Terumo (Terumo) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Terumo Corp (OTCPK:TRUMY) » Definitions » Total Equity

Comparable Companies

Traded in Other Exchanges

TRUMF:USA 4543:Japan TUO:Germany

Address

2-44-1 Hatagaya, Shibuya-ku, Tokyo, JPN, 151-0072

Website

https://www.terumo.com

Terumo Corp manufactures and sells medical products and equipment. The firm has three main businesses: blood management, cardiac and vascular, and general hospital. The cardiac and vascular business generates the largest proportion of revenue and sells cardiac and endovascular interventional therapies, cardiovascular surgical systems, neurovascular products, and vascular graft products. The general hospital business includes diabetes management, consumer healthcare, drug and device technologies, and general hospital products. The blood management business sells blood component, therapeutic apheresis, and cellular technologies. Terumo generates the majority of its revenue in Asia, with Japan contributing the largest proportion of Asian revenue.